Viatris is trading up 4.14% at $19.75 on November 6, after its November 5 third-quarter report showed an earnings beat and improved 2026 outlook. - Adjusted EPS was $0.71 versus $0.64 analyst consensus; revenue was slightly below expectations. - Management raised midpoints for 2026 revenue, adjusted EBITDA and adjusted EPS guidance. - The healthcare sector fell 1.48%, a headwind; overall market context was positive. No current volume data was available to assess activity versus average volume.